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How difficult is to go from egg to implanted embryo? The evolution of placentation in eutherian
mammals created enormous challenges, in particular to the maternal immune system, as the fetus
expresses paternal antigens that are capable of triggering immune rejection. Samstein et al. reveal
a role for inducible regulatory T cells in the enforcement of maternal-fetal immune tolerance.From the perspective of the immune
system, pregnancy presents a state akin
to organ transplantation, in which fetal
antigens are foreign to the mother’s
immune system. The fetus expresses a
combination of antigens from the mother
and the father; this combination is re-
ferred to, in immunological terms, as
semiallogeneic. The immune system of
eutherian mammals, therefore, had to
evolve mechanisms to prevent immune-
mediated rejection of the semiallogeneic
fetuses. Regulatory T cells (Treg) are
among the most important cells involved
in the establishment of immune tolerance
against self antigens and antigens en-
countered in foreign grafts. In this issue,
Samstein et al. show that a subset of Treg
cells plays an important part in maternal-
fetal immune tolerance (Samstein et al.,
2012).
Regulatory T cells are characterized by
the expression of the transcription factor
Foxp3, which is essential for their devel-
opment and maintenance. Treg cells can
follow a developmental path similar to
other T cells and emerge from the thymus
(referred to as thymic-derived Treg cells
[tTreg] or frequently as natural [nTreg]) or
differentiate extrathymically from naive
CD4+ T cells; cells in this latter subset
are known as peripherally induced Treg
cells (pTreg, or iTreg, for induced). It has
been postulated that a division of labor
exists between Foxp3+ tTreg and pTreg,
with tTreg being mainly associated with
the maintenance of immune homeostasis
and the prevention of autoimmunity;
pTreg cells are thought to be most impor-tant in establishing tolerance at inter-
faces such as the mucosal surfaces in
the lung and in the gut, where the immune
system comes into contact with the
‘‘outside’’ and is chronically exposed to
allergens and other foreign antigens.
Both tTreg and pTreg subsets are needed
to fully protect Foxp3-deficient mice from
inflammatory disease (reviewed by Bilate
and Lafaille, 2012), and now Samstein
et al. make a compelling case for the pre-
dominant involvement of pTreg cells in
maternal-fetal tolerance.
Three conserved noncoding DNA
sequences have been described in the
Foxp3 locus, namely CNS1, CNS2, and
CNS3, and are shown to regulate and
modulate the expression of foxp3 in re-
sponse to distinct cell-intrinsic and -ex-
trinsic stimuli. Among other sites, CNS1
has binding sites for Smad proteins,
which are activated in response to TGFb,
a cytokine that is essential for the differ-
entiation of pTreg cells. CNS1-deficient
mice displayed impaired generation of
pTreg cells but unaffected tTreg cell
development (Zheng et al., 2010). Sam-
stein et al. now report that interstrain
breeding of CNS1-deficient mice results
in increased resorption of the semialloge-
neic fetuses and that this is not seen with
syngeneic fetuses, the progeny of intra-
strain breedings. This correlated with the
impaired generation of paternal antigen-
specific pTreg cells at the fetal-maternal
interface. Depleting all Treg cells (tTreg
and pTreg cells) did not increase resorp-
tion rates compared to pTreg deficiency
alone, suggesting that tTregs were notCinvolved in maternal-fetal tolerance. Al-
though the experiments did not exclude
all involvement of tTreg cells in the accep-
tance of semiallogeneic fetuses, these
results highlighted the importance of
pTreg cells that develop in the decidua
of pregnant females in the process. These
findings thus add the contribution of
pTreg to the multiple redundant path-
ways operating in maternal-fetal toler-
ance. It should be noted that the absence
of all Treg cells does not result in sterility
either in semiallogeneic or syngeneic
pregnancies.
These findings also bear importance for
pregnancy complications such as pre-
eclampsia (Santner-Nanan et al., 2009),
in which defective pTreg cell generation
may take place. These authors found
that women with pre-eclampsia had a
lower frequency of Treg cells and a higher
frequency of Th17 cells, lymphocytes as-
sociated with an inflammatory response,
than women undergoing normal pregnan-
cies. Epidemiologically, pre-eclampsia
has the hallmarks of an immune response.
It occurs mainly in first pregnancies, when
the mother has had fewer opportunities to
develop tolerance against paternal anti-
gens, and inflammation is a major part of
its pathogenesis. Thus, proper develop-
ment of regulatory T cells is likely to play
a role in preventing this condition (Red-
man and Sargent, 2010).
The findings by Samstein et al. also
contain important evolutionary implica-
tions. The authors’ hypothesis of a role
for pTregs in maternal-fetal tolerance
came from phylogenetic analysis ofell 150, July 6, 2012 ª2012 Elsevier Inc. 7
Figure 1. CNS1 Is Present in Placental Mammals and Confers Foxp3+ Peripheral Treg
Differentiation Capacity to T Cells
(A) The thymus of mammals exports naive T cells (Foxp3) and thymus-generated Treg cells (tTreg).
(B) The CNS1 element in the Foxp3 gene is contained within a retrotransposon that is present in all
eutherian mammals, but not in other vertebrates. CNS1 contains, among other binding sites, a Smad-
binding site, allowing pTreg Foxp3+ differentiation from peripheral Foxp3 T cells in response to TGFb.
Due to its highly conserved sequence and role in maternal-fetal tolerance, CNS1 acquisition is likely to
have played a role during the evolution of placental mammals.
(C). Noneutherian mammals (and other vertebrates) may have less prominent peripheral Treg cells (pTreg)
and, consequently, a higher proportion of thymic-derived tTreg cells.CNS1. By aligning the CNS1 sequences
of a number of vertebrate species, in-
cluding noneutherian mammals such as
wallaby and opposum, they found that
the presence of CNS1 correlates with
the evolution of placentation; CNS1
emerges abruptly in evolution and is pre-
sent only in eutherian mammals. Interest-
ingly, the CNS1 element is contained
within a retrotransposon. The findings by
Samstein et al. indicate the possibility
that the acquisition of the TGFb-respon-
sive CNS1 element and the increased8 Cell 150, July 6, 2012 ª2012 Elsevier Inc.development of pTreg cells enhanced
maternal-fetal immune tolerance (Fig-
ure 1). Important implications of these
findings are that acquisition of CNS1
via a transposable element eventually
provided eutherian mammals with the
advantage of peripheral Treg differentia-
tion and that the dominant selective pres-
sure for the existence of pTreg cells was
to improve acceptance by the maternal
immune system of fetuses presenting
paternal antigens foreign to the mother.
Other functions of pTreg cells, such astheir role in maintaining immune tolerance
at mucosal interfaces such as the lung
and the gut, may have come as a later
adaptation. One of the many interesting
future directions will be to investigate the
differences in pTreg generation and func-
tion between eutherian and noneutherian
vertebrates, which have the Foxp3 gene
but lack a recognizable CNS1 element.
Evolution by mobile genetic elements
allows sudden changes in gene expres-
sion or changes in the expression of
blocks of genes; both the quickness and
the block changes are suitable for major
adaptation. From egg to implanted em-
bryo, eutherian mammals accumulated
many changes in their physiology to allow
the development of a fetus in the uterus.
For example, the body of the mother had
to become aware of pregnancy and,
accordingly, secrete multiple hormones
that control the large transformation of
the uterus architecture necessary for a
successful pregnancy (Wildman, 2011).
How did these changes occur during
evolution? There is evidence that many
of these changes came in blocks. For
example, analysis of gene expression in
the uterine endometrium showed that
more than 1,500 genes were recruited
into endometrial expression and that
about 13% of them were regulated by
a single eutherian-specific transposable
element, Mer20 (Lynch et al., 2011). Other
genes important to placentation, such
as the Syncytins, are also encoded
by endogenous retroviral sequences
(Nahmias et al., 2011). The findings by
Samstein et al. now add a new layer to
the importance of transposable elements
in the evolution of eutherian mammals, in-
volving in this case the adaptation of the
maternal immune system to pregnancy.
The finding that the acquisition of CNS1
was likely via a transposon insertion into
the Foxp3 locus adds to other transpos-
able events that have influenced the
immune system. An ancestral transposon
insertion might have brought recombina-
tion activating genes (RAG) 1 and 2 into
the genomes of jawed vertebrates; this
insertion was advantageous once RAG1
and RAG2 became an integral part of the
diversification of antigen receptors (Hir-
ano et al., 2011). The generation of highly
diverse antigen receptors required the
coevolution of mechanisms to control im-
mune responses targeting the individual’s
own tissues; in this light, it is interesting to
consider that the gene encoding Foxp3
appeared early in vertebrate evolution
and is present in all jawed vertebrates,
with the possible exception of birds.
Interestingly, the coding sequence of
Foxp3 became highly conserved in eu-
therian mammals (Andersen et al., 2012).
Thus, several transposable elements
acted as building blocks in the evolu-
tion of eutherian mammals, Mer20,
RAG1/2, andCNS1, eachonecontributing
to the evolutionary fitness of placental
animals.
The findings by Samstein et al. provide
unique insight into the evolution of mam-mals. The study raises questions about
the TGFb dependence of pTreg in noneu-
therian mammals and other Foxp3-
expressing vertebrates. Finally, it raises
the possibility that defects in the genera-
tion of pTreg may be at the root of condi-
tions such as pre-eclampsia.REFERENCES
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Expression of eukaryotic mRNAs requires the collaboration of a host of RNA processing factors
acting upon the transcript. Berg et al. describe how a pre-mRNA splicing factor modulates the
activity of the polyadenylation machinery to regulate mRNA length, with important implications
for isoform expression in activated neuronal and immune cells.Formation of messenger RNAs (mRNAs)
from pre-mRNA transcripts involves
multiple processing steps, including 50
end capping, intron removal via pre-
mRNA splicing, and 30 end cleavage/poly-
adenylation. Although these processes
have been studied as biochemically
distinct reactions, they each appear to
occur cotranscriptionally and in close
spatial and temporal proximity to one
another, raising important questions
about how they may act coordinately to
affect gene expression outcomes. One
of these cotranscriptional processes, pol-
yadenylation, can occur at multiple sites
in more than half of mammalian tran-
scripts (Tian et al., 2005), and genome-
wide surveys of poly(A) RNA have recently
demonstrated that 30 cleavage and polya-
denylation may occur throughout a pre-
mRNA (Kaida et al., 2010; Weill et al.,2012). In this issue, Berg and colleagues
demonstrate that U1 small nuclear RNA
(snRNA), an RNA typically associated
with splicing, regulates transcript length
through cotranscriptional recognition of
cryptic polyadenylation signals (PASs)
and inhibition of premature cleavage and
polyadenylation (PCPA) at these sites
(Figure 1) (Berg et al., 2012). This process,
which the authors term ‘‘telescripting,’’
appears to make functional contributions
to transcriptional control of activated neu-
ronal cells.
U1 snRNA is best characterized for its
role in recognizing the 50 splice site (50ss)
during removal of introns from pre-
mRNAs; however, it is present at levels
far exceeding what is necessary for pre-
mRNA splicing in the cell (Baserga and
Steitz, 1993), and it is the only snRNA
that localizes to intronless genes (Brodyet al., 2011). Additionally, the splicing-
associated U1 small nuclear ribonu-
cleoprotein (snRNP) particle inhibits
pre-mRNA polyadenylation through its
interaction with poly(A) polymerase (Gun-
derson et al., 1994, 1998). U1 snRNA
has also been implicated in a splicing-
independent role in transcriptional activa-
tion (Kwek et al., 2002), and the Dreyfuss
lab previously described a role for U1 in
protecting pre-mRNAs from cleavage
and polyadenylation (Kaida et al., 2010).
Although integral to pre-mRNA splicing,
these observations point to nonsplicing
functions for the U1 snRNA and perhaps
its associated proteins.
The Kaida et al. (2010) study described
above found that U1 snRNA bound to
cryptic 50ss within the mRNA protected
internal PASs from premature process-
ing. To look more closely at how U1ell 150, July 6, 2012 ª2012 Elsevier Inc. 9
